These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21060029)

  • 21. Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001.
    Kimmick GG; Peterson BL; Kornblith AB; Mandelblatt J; Johnson JL; Wheeler J; Heinze R; Cohen HJ; Muss HB
    J Clin Oncol; 2005 Apr; 23(10):2201-7. PubMed ID: 15800312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experience of the National Cancer Institute Community Cancer Centers Program on Community-Based Cancer Clinical Trials Activity.
    Hirsch BR; Locke SC; Abernethy AP
    J Oncol Pract; 2016 Apr; 12(4):e350-8. PubMed ID: 27026649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Some practical aspects of the interim monitoring of clinical trials.
    Simon R
    Stat Med; 1994 Jul 15-30; 13(13-14):1401-9. PubMed ID: 7973219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute-Designated Cancer Program.
    Mantripragada KC; Olszewski AJ; Schumacher A; Perez K; Birnbaum A; Reagan JL; Mega A; Khurshid H; Bartley C; Lombardo A; Rossiter R; Papa A; Bakalarski P; Safran H
    J Oncol Pract; 2016 Apr; 12(4):e396-404. PubMed ID: 26907448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.
    Denicoff AM; McCaskill-Stevens W; Grubbs SS; Bruinooge SS; Comis RL; Devine P; Dilts DM; Duff ME; Ford JG; Joffe S; Schapira L; Weinfurt KP; Michaels M; Raghavan D; Richmond ES; Zon R; Albrecht TL; Bookman MA; Dowlati A; Enos RA; Fouad MN; Good M; Hicks WJ; Loehrer PJ; Lyss AP; Wolff SN; Wujcik DM; Meropol NJ
    J Oncol Pract; 2013 Nov; 9(6):267-76. PubMed ID: 24130252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The generalizability of NCI-sponsored clinical trials accrual among women with gynecologic malignancies.
    Mishkin G; Minasian LM; Kohn EC; Noone AM; Temkin SM
    Gynecol Oncol; 2016 Dec; 143(3):611-616. PubMed ID: 27697287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
    Adis International Ltd
    Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of the National Cancer Institute Community Cancer Centers Program screening and accrual log to address cancer clinical trial accrual.
    St Germain D; Denicoff AM; Dimond EP; Carrigan A; Enos RA; Gonzalez MM; Wilkinson K; Mathiason MA; Duggan B; Einolf S; McCaskill-Stevens W; Bryant DM; Thompson MA; Grubbs SS; Go RS
    J Oncol Pract; 2014 Mar; 10(2):e73-80. PubMed ID: 24424313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustainability and performance of the National Cancer Institute's Community Clinical Oncology Program.
    Carpenter WR; Fortune-Greeley AK; Zullig LL; Lee SY; Weiner BJ
    Contemp Clin Trials; 2012 Jan; 33(1):46-54. PubMed ID: 21986391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stopping or reporting early for positive results in randomized clinical trials: the National Cancer Institute Cooperative Group experience from 1990 to 2005.
    Korn EL; Freidlin B; Mooney M
    J Clin Oncol; 2009 Apr; 27(10):1712-21. PubMed ID: 19237631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unsuccessful trial accrual and human subjects protections: an empirical analysis of recently closed trials.
    Carlisle B; Kimmelman J; Ramsay T; MacKinnon N
    Clin Trials; 2015 Feb; 12(1):77-83. PubMed ID: 25475878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leveraging National Cancer Institute Programmatic Collaboration for Uterine Cervix Cancer Patient Accrual in Puerto Rico.
    Kunos CA; Massett HA; Galassi A; Walker JL; Good MJ; Díaz LB; McCaskill-Stevens W
    Front Oncol; 2018; 8():102. PubMed ID: 29692980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating the rate and reasons of clinical trial failure in urologic oncology.
    Stensland KD; DePorto K; Ryan J; Kaffenberger S; Reinstatler LS; Galsky M; Canes D; Skolarus TA; Moinzadeh A
    Urol Oncol; 2021 Mar; 39(3):154-160. PubMed ID: 33257221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Who's Eligible Anyway? Risk Modeling for Clinical Trial Accrual.
    Mileham KF; Kim ES
    Clin Cancer Res; 2016 Nov; 22(22):5397-5399. PubMed ID: 27601589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What drives cancer clinical trial accrual? An empirical analysis of studies leading to FDA authorisation (2015-2020).
    Jenei K; Haslam A; Olivier T; Miljkovíc M; Prasad V
    BMJ Open; 2022 Oct; 12(10):e064458. PubMed ID: 36207035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Globalization of Cooperative Groups.
    Valdivieso M; Corn BW; Dancey JE; Wickerham DL; Horvath LE; Perez EA; Urton A; Cronin WM; Field E; Lackey E; Blanke CD
    Semin Oncol; 2015 Oct; 42(5):693-712. PubMed ID: 26433551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enrolling Older Adults Onto National Cancer Institute-Funded Clinical Trials in Community Oncology Clinics: Barriers and Solutions.
    Hopkins JO; Braun-Inglis C; Guidice S; Wells M; Moorthi K; Berenberg J; St Germain D; Mohile S; Hudson MF
    J Natl Cancer Inst Monogr; 2022 Dec; 2022(60):117-124. PubMed ID: 36519815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of independent data-monitoring committees in randomized clinical trials sponsored by the National Cancer Institute.
    Smith MA; Ungerleider RS; Korn EL; Rubinstein L; Simon R
    J Clin Oncol; 1997 Jul; 15(7):2736-43. PubMed ID: 9215848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategies to improve success of pediatric cancer cooperative group quality of life studies: a report from the Children's Oncology Group.
    Whitlow PG; Caparas M; Cullen P; Trask C; Schulte F; Embry L; Nagarajan R; Johnston DL; Sung L
    Qual Life Res; 2015 Jun; 24(6):1297-301. PubMed ID: 25429821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of esophagogastric cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase 1 trials.
    Bando H; Rubinstein L; Harris P; Yoshino T; Doi T; Ohtsu A; Welch J; Takebe N
    Gastric Cancer; 2017 May; 20(3):481-488. PubMed ID: 27510411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.